BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34645620)

  • 1. Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of 'compassionate therapies' in times of catastrophic pandemics.
    Zuckerman S; Barlavie Y; Niv Y; Arad D; Lev S
    J Med Ethics; 2022 Dec; 48(12):1000-1005. PubMed ID: 34645620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 3. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panic prescribing has become omnipresent during the COVID-19 pandemic.
    Caplan AL; Upshur R
    J Clin Invest; 2020 Jun; 130(6):2752-2753. PubMed ID: 32330122
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic.
    Shah SK; Wendler D; Danis M
    Am J Bioeth; 2015; 15(4):11-6. PubMed ID: 25856592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ebola clinical trials: a precedent for research ethics in disasters.
    Calain P
    J Med Ethics; 2018 Jan; 44(1):3-8. PubMed ID: 27573153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If it walks like a duck…: Monitored Emergency Use of Unregistered and Experimental Interventions (MEURI) is research.
    Schaefer GO
    J Med Ethics; 2023 Nov; ():. PubMed ID: 38050144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
    Dzhafer N; Papathanasiou JV
    Folia Med (Plovdiv); 2020 Sep; 62(3):592-596. PubMed ID: 33009760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Ebola virus disease on maternal health service utilisation and perinatal outcomes in West Africa: a systematic review.
    Kassa ZY; Scarf V; Fox D
    Reprod Health; 2022 Feb; 19(1):35. PubMed ID: 35120540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from the Ebola epidemics and their applications for COVID-19 pandemic response in sub-Saharan Africa.
    Afolabi MO; Folayan MO; Munung NS; Yakubu A; Ndow G; Jegede A; Ambe J; Kombe F
    Dev World Bioeth; 2021 Mar; 21(1):25-30. PubMed ID: 32654261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies.
    Beall RF; Moradpour J; Hollis A
    PLoS One; 2021; 16(10):e0258013. PubMed ID: 34679120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.